| P50 | author | davide gatti | Q58150575 |
| | Luca Idolazzi | Q58348555 |
| | Francesco Ghellere | Q85932366 |
| P2093 | author name string | Maurizio Rossini | |
| | Silvano Adami | |
| | Roberta Zanotti | |
| | Ombretta Viapiana | |
| | Riccardo Ortolani | |
| | Gaia Tripi | |
| P2860 | cites work | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Denosumab for prevention of fractures in postmenopausal women with osteoporosis | Q28254528 |
| | Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab | Q28265584 |
| | Denosumab in postmenopausal women with low bone mineral density | Q28298728 |
| | Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo | Q34153374 |
| | Effects of denosumab on bone mineral density and bone turnover in postmenopausal women | Q34656025 |
| | Osteoclast activity modulates B-cell development in the bone marrow | Q35348955 |
| | Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization | Q35441456 |
| | Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association? | Q35643989 |
| | B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo | Q35804512 |
| | Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus | Q35908596 |
| | Role of T cells in the modulation of PTH action: physiological and clinical significance | Q37274471 |
| | Do RANKL inhibitors (denosumab) affect inflammation and immunity? | Q37767159 |
| | Skeletal and extraskeletal actions of denosumab. | Q38009712 |
| | Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab | Q44416716 |
| | Acute phase response after zoledronic acid is associated with long-term effects on white blood cells. | Q45731159 |
| | A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women | Q46133598 |
| | Vγ9 Vδ2 T lymphocytes activation as a novel approach to test efficacy of different bisphosphonates | Q59535965 |
| P433 | issue | 3 | |
| P304 | page(s) | 857-859 | |
| P577 | publication date | 2015-08-20 | |
| P1433 | published in | Endocrine | Q15757048 |
| P1476 | title | Effects of denosumab on peripheral lymphocyte subpopulations | |
| P478 | volume | 53 | |